SENSOLYTIC

Serial Number 87459108
Registration 5956012
700

Registration Progress

Application Filed
May 22, 2017
Under Examination
Nov 28, 2017
Approved for Publication
Oct 3, 2017
Published for Opposition
Oct 3, 2017
Registered
Jan 7, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200107) (Grace Period Filing)
Due: Jul 07, 2026 Grace Period - 175 days
Original deadline was Jan 07, 2026 (overdue)

Trademark Image

SENSOLYTIC

Basic Information

Serial Number
87459108
Registration Number
5956012
Filing Date
May 22, 2017
Registration Date
January 7, 2020
Published for Opposition
October 3, 2017
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 7, 2020
Registration
Registered
Classes
005

Rights Holder

Oisín Biotechnologies, Inc.

03
Address
701 Fifth Avenue, Suite 4200
Seattle, WA 98104

Ownership History

Oisín Biotechnologies, Inc.

Original Applicant
03
Seattle, WA

Oisín Biotechnologies, Inc.

Owner at Publication
03
Seattle, WA

Oisín Biotechnologies, Inc.

Original Registrant
03
Seattle, WA

Legal Representation

Attorney
Paul A. Spiegel

USPTO Deadlines

Next Deadline
In Grace Period
Section 8 Declaration Due (Principal Register) (Based on registration date 20200107)
Due Date
January 07, 2026
Grace Period Ends
July 07, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

33 events
Date Code Type Description Documents
Jan 7, 2026 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Jan 7, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Jan 7, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 4, 2019 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 3, 2019 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Nov 8, 2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 8, 2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 8, 2019 ALIE A ASSIGNED TO LIE Loading...
Nov 2, 2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 3, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 3, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 3, 2019 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Apr 23, 2019 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Apr 10, 2019 IUAF S USE AMENDMENT FILED Loading...
Apr 23, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Apr 10, 2019 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Nov 7, 2018 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 6, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 2, 2018 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 2, 2018 EXT2 S SOU EXTENSION 2 FILED Loading...
Nov 2, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 23, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 21, 2018 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 21, 2018 EXT1 S SOU EXTENSION 1 FILED Loading...
May 21, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 28, 2017 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 3, 2017 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 3, 2017 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 13, 2017 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 21, 2017 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 21, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
May 26, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 25, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biological preparations for the treatment of age-related diseases; Biological preparations for the treatment of cancer; Medical preparations for the treatment of age-related diseases and cancer; Pharmaceutical preparations for the treatment and prevention of age-related diseases and cancer; Pharmaceutical preparations for the treatment of age-related diseases and cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceutical for the treatment of age-related diseases and cancer
First Use Anywhere: 20160000
First Use in Commerce: 20180300

Classification

International Classes
005